These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


724 related items for PubMed ID: 26220012

  • 1. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M, Asadi-Kani Z, Mozafari N, Vahidnezhad H, Kariminejad A, Toossi P.
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunofluorescence mapping, electron microscopy and genetics in the diagnosis and sub-classification of inherited epidermolysis bullosa: a single-centre retrospective comparative study of 87 cases with long-term follow-up.
    Rossi S, Castiglia D, Pisaneschi E, Diociaiuti A, Stracuzzi A, Cesario C, Mariani R, Floriddia G, Zambruno G, Boldrini R, Abeni D, Novelli A, Alaggio R, El Hachem M.
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):1007-1016. PubMed ID: 33274474
    [Abstract] [Full Text] [Related]

  • 4. Rapid diagnosis of major variants of congenital epidermolysis bullosa using a monoclonal antibody against collagen type IV.
    Bolte C, Gonzalez S.
    Am J Dermatopathol; 1995 Dec; 17(6):580-3. PubMed ID: 8599472
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A comparative study of immunohistochemistry and electron microscopy used in the diagnosis of epidermolysis bullosa.
    Petronius D, Bergman R, Ben Izhak O, Leiba R, Sprecher E.
    Am J Dermatopathol; 2003 Jun; 25(3):198-203. PubMed ID: 12775981
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutation analysis and molecular genetics of epidermolysis bullosa.
    Pulkkinen L, Uitto J.
    Matrix Biol; 1999 Feb; 18(1):29-42. PubMed ID: 10367729
    [Abstract] [Full Text] [Related]

  • 9. The Role of Collagen IV and Cytokeratin 5/6 Immunohistochemistry in Identifying Subtypes of Hereditary Epidermolysis Bullosa.
    Alhumidi A.
    Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):586-590. PubMed ID: 27941563
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathogenesis of mechanobullous disorders.
    Bruckner-Tuderman L.
    Exp Dermatol; 1992 Oct; 1(3):115-20. PubMed ID: 1365310
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Neonatal epidermolysis bullosa: lessons to learn about genetic counseling.
    Chong SC, Hon KL, Yuen LYP, Choi PCL, Ng WGG, Chiu TW.
    J Dermatolog Treat; 2021 Feb; 32(1):29-32. PubMed ID: 30280950
    [Abstract] [Full Text] [Related]

  • 14. Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa.
    Rao R, Shetty VM.
    Indian J Dermatol; 2021 Feb; 66(4):360-365. PubMed ID: 34759393
    [Abstract] [Full Text] [Related]

  • 15. Next-generation sequencing through multigene panel testing for the diagnosis of hereditary epidermolysis bullosa in Chinese population.
    Chen F, Huang L, Li C, Zhang J, Yang W, Zhang B, Li H, Deng D, Liang J, Shen J, Yao Z, Li M.
    Clin Genet; 2020 Aug; 98(2):179-184. PubMed ID: 32484238
    [Abstract] [Full Text] [Related]

  • 16. Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa.
    Bergson S, Daniely D, Bomze D, Mohamad J, Malovitski K, Meijers O, Briskin V, Bihari O, Malchin N, Israeli S, Mashiah J, Falik-Zaccai T, Avitan-Hersh E, Eskin-Schwartz M, Allon-Shalev S, Sarig O, Sprecher E, Samuelov L.
    Pediatr Dermatol; 2023 Aug; 40(6):1021-1027. PubMed ID: 37827535
    [Abstract] [Full Text] [Related]

  • 17. Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: missense versus nonsense.
    Pulkkinen L, Rouan F, Bruckner-Tuderman L, Wallerstein R, Garzon M, Brown T, Smith L, Carter W, Uitto J.
    Am J Hum Genet; 1998 Nov; 63(5):1376-87. PubMed ID: 9792864
    [Abstract] [Full Text] [Related]

  • 18. LDA-1 monoclonal antibody. An excellent reagent for immunofluorescence mapping studies in patients with epidermolysis bullosa.
    Fine JD, Gay S.
    Arch Dermatol; 1986 Jan; 122(1):48-51. PubMed ID: 3510588
    [Abstract] [Full Text] [Related]

  • 19. Epidermolysis Bullosa: Pediatric Perspectives.
    Hon KL, Chu S, Leung AKC.
    Curr Pediatr Rev; 2022 Jan; 18(3):182-190. PubMed ID: 34036913
    [Abstract] [Full Text] [Related]

  • 20. Molecular basis of the dystrophic and junctional forms of epidermolysis bullosa: mutations in the type VII collagen and kalinin (laminin 5) genes.
    Uitto J, Pulkkinen L, Christiano AM.
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):39S-46S. PubMed ID: 7963683
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.